Pancreatic Cancer Research

ResearcherUniversity of California, Los AngelesActive in the last 2 years

Hui-Hua Chang

Matched on ORCID iD 0000-0001-6369-0326; OpenAlex author ID A5102865018. Sources: OpenAlex.

Their work

Papers
13 (first author 5, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: 3 papers · 2018: 3 papers · 2019: 3 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 13

  1. Upregulated Matrisomal Proteins and Extracellular Matrix Mechanosignaling Underlie Obesity-Associated Promotion of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers16081593↗
  2. Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity. First author DOI 10.1152/ajpgi.00170.2019↗
  3. Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pa… Co-author DOI 10.1371/journal.pone.0216603↗
  4. Obesity-Induced Adipose Tissue Inflammation as a Strong Promotional Factor for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cells8070673↗
  5. Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model. Co-author DOI 10.1038/s41598-018-24337-8↗
  6. Deficiency in hormone-sensitive lipase accelerates the development of pancreatic cancer in conditional KrasG12D mice. First author DOI 10.1186/s12885-018-4713-y↗
  7. Deficiencies in Natural Killer Cell Numbers, Expansion, and Function at the Pre-Neoplastic Stage of Pancreatic Cancer by KRAS Mutation in the Pancreas of Obese… First author DOI 10.3389/fimmu.2018.01229↗
  8. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism. Co-author DOI 10.1016/j.surg.2016.12.037↗
  9. Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice. Co-author DOI 10.1371/journal.pone.0184455↗
  10. Suppression of Gingival NK Cells in Precancerous and Cancerous Stages of Pancreatic Cancer in KC and BLT-Humanized Mice. First author DOI 10.3389/fimmu.2017.01606↗
  11. Robust Early Inflammation of the Peripancreatic Visceral Adipose Tissue During Diet-Induced Obesity in the KrasG12D Model of Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000497↗
  12. E-cadherin expression in obesity-associated, Kras-initiated pancreatic ductal adenocarcinoma in mice. First author DOI 10.1016/j.surg.2015.07.023↗
  13. miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cells. Co-author DOI 10.1016/j.bbrc.2013.08.042↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guido Eibl · 13 shared papers, 2013–2024 · strength 1.21
  2. Enrique Rozengurt · 7 shared papers, 2017–2024 · strength 0.68
  3. Oscar Joe Hines · 7 shared papers, 2013–2018 · strength 0.42
  4. James W. Sinnett‐Smith · 5 shared papers, 2017–2019 · strength 0.38
  5. David W. Dawson · 4 shared papers, 2016–2018 · strength 0.26
  6. Aurelia Lugea Reta · 2 shared papers, 2017–2024 · strength 0.25
  7. Richard T. Waldron · 2 shared papers, 2017–2024 · strength 0.25
  8. Stephen Jacob Pandol · 2 shared papers, 2017–2024 · strength 0.25
  9. Andrea Schmidt · 3 shared papers, 2015–2018 · strength 0.20
  10. Kawaljit Kaur · 2 shared papers, 2017–2018 · strength 0.18
  11. Anahid Jewett · 2 shared papers, 2017–2018 · strength 0.18
  12. Hao Fang · 2 shared papers, 2018–2019 · strength 0.18
  13. Kathleen M. Hertzer · 3 shared papers, 2013–2016 · strength 0.14
  14. Mu Xu · 2 shared papers, 2016–2018 · strength 0.13
  15. Alexander P. Stark · 2 shared papers, 2015–2016 · strength 0.11
  16. Tien Sy Dong · 1 shared paper, 2019 · strength 0.10
  17. Qinhong Xu · 1 shared paper, 2019 · strength 0.10
  18. Jonathan C. King · 1 shared paper, 2018 · strength 0.08
  19. Gang Li · 1 shared paper, 2017 · strength 0.05
  20. Kazuki Takakura · 1 shared paper, 2017 · strength 0.05
  21. Anna S. Gukovskaya · 1 shared paper, 2017 · strength 0.05
  22. Vay Liang W. Go · 1 shared paper, 2017 · strength 0.05
  23. Graham W. Donald · 1 shared paper, 2013 · strength 0.03
  24. Howard A. Reber · 1 shared paper, 2013 · strength 0.03
  25. Hung Pham · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.